Table 2.

Summary of changes across development between the neonatal and adult age groups for each of the three samples.

Transcript	Layer 3 Pyramidal Cells			Layer 3		Layer 6
	% Change from Neonatal to Adult Age Groups	p-value	Age Group when Adult Levels Reached	% Change from Neonatal to Adult Age Groups	p-value	% Change from Neonatal to Adult Age Groups	p-value
CDC42	−35.1%	<0.001	Prepubertal	−28.0%	0.178	−21.5%	0.32
CDC42EP3	−46.0%	0.004	Infant	−22.4%	0.368	−27.3%	0.085
Cofilin	−17.9%	0.1	Infant	−11.4%	0.843	−16.2%	0.372
RhoA	−28.6%	0.03	Infant	−5.5%	0.93	29.0%	0.069
PAK1	58.1%	0.002	Infant	99.3%	<0.001	111.8%	<0.001
N-cadherin	57.3%	0.001	Prepubertal	46.1%	0.349	15.2%	0.871
LIMK1	107.5%	<0.001	Adult	107.8%	0.011	69.7%	0.064
CDC42EP4	−43.6%	0.186	Neonatal	27.9%	0.471	45.4%	0.391
ARHGDIA	−19.2%	0.721	Neonatal	−19.4%	0.984	−7.9%	1
SEPT7	8.2%	0.806	Neonatal	38.5%	0.422	77.1%	0.008